Data mining for signals in spontaneous reporting database: Proceed with caution

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 359-365

  Stephenson, Wendy P ^a,b   Hauben, Manfred ^c,d,e  

^a Wendy Stephenson and Associates LLC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PFIZER INC   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adverse drug reactions; Data mining; Pharmacovigilance; Proportional reporting ratios; Signal detection; Spontaneous reporting systems; Statistical methods

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ALGORITHM; ARTICLE; BIBLIOGRAPHIC DATABASE; CONSUMER HEALTH INFORMATION; DATA MINING; DRUG INDICATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; MEDICAL RESEARCH; METHODOLOGY; POISSON DISTRIBUTION; POSTMARKETING SURVEILLANCE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL DETECTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DATABASES; DRUG THERAPY; HUMANS; PHARMACOEPIDEMIOLOGY; RISK ASSESSMENT;

EID: 34247464176     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1323     Document Type: Article

References (21)

1. Trontell A. Expecting the unexpected drug safety, pharmacovigilance and the prepared mind. NEJM 2004; 351(14): 1385-1387.
2. International Reporting of Periodic Drug-Safety Update Summaries. Final report of CIOMS Working Group II. Council for International Organizations of Medical Sciences, Geneva, 1992.
3. ICH E2C Clinical Safety Data Management. Periodic Safety Update Reports for Marketed Drugs. (See http://www.ich.org). Step 5 as of November 1996.
4. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2003; 57: 127-134.
5. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-486.
6. Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Safe 2002; 25: 393-397.
7. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999; 53: 177-190.
8. Purcell P, Barty S. Statistical techniques for signal generation: the Australian experience. Drug Safe 2002; 25(6): 415-421.
9. Hauben M, Patadia V, Gerrits C, Walsh L, Reich L. Data mining in pharmacovigilance: the need for a balanced perspective. Drug Safe 2005; 28(10): 835-842.
10. Hauben M, Madigan D, Gerrits CM, Walsh L, van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Safe 2005; 4(5): 929-948.
11. Niu MT, Erwin DE, Braun MM. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001; 19: 4627-4634.
12. Hauben M. Trimethoprim-induced hyperkalaemia - lessons in data mining. Br J Clin Pharmacol 2004.
13. Hauben M. Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics. Pharmacotherapy 2004; 24(9): 1122-1129.
14. Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol 2004; 58(5): 560-562.
15. Hand DJ, Blunt G, Kelly MG, Adama. NM. Data mining for fun and profit. Stat Sci 2000; 15(2): 111-131.
16. van der Heijden PG, van Puijenbrock EP, van Buren SS, van der Hofsted JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med 2002; 21(14): 2027-2044.
17. Waller P, van Puijenbroek EP, Egberts; A, Evans S. The reporting adds ratio versus the proportional reporting ratio: 'deuce'. Pharmacoepidemiol Drug Saf 2004; 13: 525-526.
18. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Safe 2002; 25: 381-392.
19. Weber JCP. Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In Advances In Inflammation Research, Vol. 6, Rainsford KD, Velo GP (eds). Raven Press: New York, NY, 1984; 1-6.
20. Hartnell NF, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Pharmacotherapy 2004; 24(6): 743-749.
21. Development and Rational Use of Standardized MedDRA Queries (SMQs). Retrieving Adverse Drug Reactions with MedDRA. Report of the CIOMS Working Group. Council for International Organizataions of Medical Sciences, Geneva, 2004.